Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q3 2025 Earnings

5AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.36

-1.07

-0.78

-0.49

Details

Expected EPS

-0.753636

Actual EPS

-0.49

Surprise EPS

0.26

Surprise Percent

+34.98%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.49 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.